Oral Solid Dose Formulations

iDPC can tailor coatings to modulate dissolution performances either to enhance or delay drug release profiles to deliver a targeted profile, whilst enhancing stability and optimising form manufacture.

oral formulation

APT has extensive experience in solving complex formulation and process development challenges, our experts and proprietary iDPC technology can support your optimisation of lead compounds from pre-formulation up to clinical manufacturing and beyond

Oral Formulations

Oral formulations
oral dissolution profile
Enhanced dissolution of poorly soluble API through iDPC formulation development.
Screenshot 2023 01 24 1.04.28 PM Display 1
iDPC modulates and tailors API release profile through application of different coatings to deliver the desired dissolution profile.